Clinical Trial

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Name: An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours — clinical trial record (NCT06695689)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label, exploratory study to evaluate safety and efficacy of LM303 Injection in patients with advanced solid tumors. The purpose of this study is to evaluate the safety and tolerability, antitumor activity and immunoreactivity.

Trial Details

NCT Number	NCT06695689
Lead Sponsor	Suzhou BlueHorse Therapeutics Co., Ltd.
Conditions	Solid Tumor
Enrollment	10 participants
Start Date	2024-10-17
Primary Completion	2026-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2024-11-19